Conflombardia – Europa
Territori d’Europa
Tutti gli articoli
www.ema.europa.eu CVMP opinions on veterinary medicinal products The Committee adopted a positive opinion for a marketing authorisation for Nobivac NXT HCPChFeLV, for the active immunisation of cats to reduce mortality, clinical signs and virus excretion caused by infection with feline...
www.ema.europa.eu CVMP opinions on veterinary medicinal products The Committee adopted a positive opinion for a marketing authorisation for Nobivac NXT HCPChFeLV, for the active immunisation of cats to reduce mortality, clinical signs and virus excretion caused by infection with feline...
www.ema.europa.eu EMA has recommended granting a marketing authorisation in the EU for Nobivac NXT HCPChFeLV, a vaccine for protecting cats against common infectious diseases. The vaccine targets five pathogens: feline herpesvirus type 1, a highly contagious virus causing disease of the...
www.ema.europa.eu New safety information for healthcare professionals Ontozry (cenobamate): new requirements for liver monitoring due to reports of severe liver injury PRAC agreed on a direct healthcare professional communication (DHPC) to inform healthcare professionals that cases of...
www.ema.europa.eu EMA’s human medicines committee (CHMP) has issued a draft qualification opinion for a new methodology in preclinical research, which can reduce the overall number of animals (rats) used in specific dose-range finding studies. This method replaces standard (concurrent)...
www.ema.europa.eu EMA's office is closed from 18:00 on Wednesday 1 April 2026 to 08:30 on Tuesday 7 April 2026. Outside of working hours and on public holidays, it is possible to call the product emergency hotline on +31(0)88 781 7600. Please note that this is an emergency number and should...